DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $28.40 Average PT from Brokerages

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has received an average recommendation of “Hold” from the twelve research firms that are currently covering the stock, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $27.91.

A number of research analysts have weighed in on XRAY shares. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd. Morgan Stanley lowered their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a report on Tuesday. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, Mizuho initiated coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target for the company.

DENTSPLY SIRONA Stock Down 2.7 %

XRAY opened at $18.68 on Monday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The company has a market cap of $3.71 billion, a price-to-earnings ratio of -9.02, a PEG ratio of 1.93 and a beta of 0.96. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $37.60. The business’s fifty day moving average is $21.07 and its two-hundred day moving average is $24.04.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. The business had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business’s revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.49 EPS. Analysts anticipate that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 3.43%. The ex-dividend date is Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in XRAY. UMB Bank n.a. raised its stake in DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after acquiring an additional 753 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in shares of DENTSPLY SIRONA in the 3rd quarter worth $27,000. LRI Investments LLC lifted its holdings in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares during the period. Rothschild Investment LLC bought a new position in DENTSPLY SIRONA during the second quarter valued at about $32,000. Finally, Kennebec Savings Bank bought a new position in DENTSPLY SIRONA during the third quarter valued at about $35,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.